C2 THERAPEUTICS
C2 Therapeutics, Inc. develops ablation therapies to treat diseases of the gastrointestinal tract. C2 Therapeutics, Inc. was incorporated in 2007 and is based in Redwood City, California.
C2 THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.c2therapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 556 1145
Email Addresses:
[email protected]
Total Funding:
21.51 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API Google Maps For Work
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
NephRx Corporation
NephRx Corporation develops therapeutic products for acute kidney failure, renal disorders, and diseases of the gastrointestinal tract.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Founder
Official Site Inspections
http://www.c2therapeutics.com
- Host name: 77-104-138-40.no-dns-yet.in-addr.zen.co.uk
- IP address: 77.104.138.40
- Location: Chicago United States
- Latitude: 41.8483
- Longitude: -87.6517
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60602
More informations about "C2 Therapeutics"
Management - MC2 Therapeutics
MC2 Therapeutics drives innovation and program development from a lean core organization in close collaboration with a network of highly specialized, fully integrated and contributing …See details»
C2 Therapeutics - Crunchbase Company Profile
C2 Therapeutics, Inc. develops ablation therapies to treat diseases of the gastrointestinal tract. C2 Therapeutics, Inc. was incorporated in 2007 and is based in Redwood City, California.See details»
C2 Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for C2 Therapeutics, Inc. of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»
About us - MC2 Therapeutics
MC2 Therapeutics is a privately held company creating a new prescription treatment for psoriasis. PAD™️ Technology enables higher patient satisfaction. Learn MoreSee details»
MC2 Therapeutics - Crunchbase Company Profile
MC2 Therapeutics drives innovation and program development from a lean core organization in close collaboration with a network of highly specialized, fully integrated and contributing experts and service providers. In addition to our …See details»
MC2 Therapeutics - LinkedIn
MC2 Therapeutics is a private pharmaceutical company dedicated to improving the lives of people with plaque psoriasis and inflamed dry and itchy skin through innovative and effective …See details»
C2 Therapeutics 2025 Company Profile: Valuation, …
C2 Therapeutics General Information Description. Provider of hospital equipment and supplies. The company provides ablation therapies to improve treatment of precursors to esophageal cancer.See details»
Mc2 Therapeutics AS
For additional information on MC2 Therapeutics, please visit https://www.mc2therapeutics.com Contact: Lonni Goltermann, +45 2018 1111, [email protected] About Paladin …See details»
C2 Therapeutics - Contacts, Employees, Board Members
C2 Therapeutics develops ablation therapies to treat diseases of the gastrointestinal tract.See details»
C2 Therapeutics - Products, Competitors, Financials, Employees ...
It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the …See details»
MC2 Therapeutics - VentureRadar
"MC2 Therapeutics is a privately held pharmaceutical company focused on topical therapies for chronic inflammatory conditions. Using its proprietary PAD™ Technology MC2 Therapeutics is …See details»
C2 Therapeutics Inc - Company Profile and News
Company profile page for C2 Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Owners - MC2 Therapeutics
MC2 Therapeutics is a privately held company that is supported by strong owners. Read More.See details»
Mc2 Therapeutics AS (Mc2 Therapeutics AS) - 药物管线_专利_临床 …
May 1, 2023 For additional information on MC2 Therapeutics, please visit https://www.mc2therapeutics.com Contact: Lonni Goltermann, +45 2018 1111, …See details»
Endo Announces Agreement for Paladin Pharma to Commercialize …
Nov 15, 2024 About MC2 Therapeutics (www.mc2therapeutics.com) ... Organization Profile. Endo, Inc. Also from this source. Endo to Report Fourth Quarter and Full Year 2024 Financial …See details»
Endo Announces Agreement for Paladin Pharma to Commercialize …
Nov 15, 2024 Paladin has a focused marketing, medical and sales organization that has helped it evolve into one of Canada's leading specialty pharmaceutical companies. ... visit …See details»
MC2 Therapeutics-MC2 Therapeutics A/S-企业详情-InvestGO
Dec 31, 2005 查看医药魔方InvestGO®数据库MC2 Therapeutics的公司信息。MC2 Therapeutics（MC2 Therapeutics A/S），公司简介：MC2 Therapeutics drives innovation and …See details»
Privacy Policy - MC2 Therapeutics
To answer your inquiries requested via our official e-mail accounts: [email protected], [email protected], [email protected], and …See details»
Endo Announces Agreement for Paladin Pharma to Commercialize …
Nov 15, 2024 Paladin has a focused marketing, medical and sales organization that has helped it evolve into one of Canada’s leading specialty pharmaceutical companies. Paladin is an …See details»
Novartis receives third FDA approval for oral Fabhalta® (iptacopan ...
2 days ago Novartis receives third FDA approval for oral Fabhalta ® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G). Phase III study showed sustained …See details»